Heterogenous biochemical expression of hormone activity in subclinical/overt hyperthyroidism and exogenous thyrotoxicosis
Open Access
- 1 March 2020
- journal article
- research article
- Published by Elsevier in Journal of Clinical & Translational Endocrinology
- Vol. 19, 100219
Abstract
No abstract availableKeywords
This publication has 58 references indexed in Scilit:
- Is pituitary TSH an adequate measure of thyroid hormone-controlled homoeostasis during thyroxine treatment?European Journal of Endocrinology, 2013
- TSH and Thyrotropic Agonists: Key Actors in Thyroid HomeostasisJournal of Thyroid Research, 2012
- Subclinical Hyperthyroidism and the Risk of Coronary Heart Disease and MortalityArchives of internal medicine (1960), 2012
- Levothyroxine Monotherapy Cannot Guarantee Euthyroidism in All Athyreotic PatientsPLOS ONE, 2011
- The Disaggregation of Within-Person and Between-Person Effects in Longitudinal Models of ChangeAnnual Review of Psychology, 2011
- Cardiovascular involvement in patients with different causes of hyperthyroidismNature Reviews Endocrinology, 2010
- Natural history of subclinical hyperthyroidism in elderly patients with TSH between 0·1 and 0·4 mIU/l: a prospective studyClinical Endocrinology, 2010
- The Many Causes of Subclinical HyperthyroidismThyroid®, 1996
- Replacement therapy for hypothyroidism with thyroxine alone does not ensure euthyroidism in all tissues, as studied in thyroidectomized rats.Journal of Clinical Investigation, 1995
- The incidence of thyroid disorders in the community: a twenty‐year follow‐up of the Whickham SurveyClinical Endocrinology, 1995